menu
    • menu

    Company profile for Polfa Tarchomin

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials a...
    Polfa Tarchomin located in Warsaw is pharmaceutical company with long tradition and experience in manufacturing and sales of pharmaceutical products. Our core business is related with: anti-infectives, CNS medicines, dermatology drugs and human insulin preparations. In general we are in position to produce: tablets and coated tablets; hard gelatinous capsules; dry bottled syrups; sterile powders for injections in glass vials and liquids in glass ampoules; insulin cartridges; dermatological: aerosols, solutions, gels. Polfa Tarchomin will be in position to produce high-potency injectables (vials and prefilled syringes) in 2025.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Polfa TarchominPoland Flag
    Country
    Country
    Poland
    Address
    Address
    A. Fleminga 2 street, 03-176 Warsaw
    Telephone
    Telephone
    +48 225108333
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.polfa-tarchomin.com.pl/en/home/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/polfa-tarchomin/
    youtube
    YouTube
    https://www.youtube.com/@PolfaTarchominSA
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Distribution of PolhuminPen injectors
    Distribution of PolhuminPen injectors

    01 Dec 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/availability-of-elenium/

    PRESS RELEASE
    01 Dec 2025
    Share Share
    Success in the development of the medicinal product Dapagliflozin
    Success in the development of the medicinal product Dapagliflozin

    23 Oct 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/success-in-the-development-of-the-medicinal-product-dapagliflozinum-10-mg/

    PRESS RELEASE
    23 Oct 2025
    Share Share
    Center for Development and Production of Highly Potent Drugs
    Center for Development and Production of Highly Potent Drugs

    23 Oct 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/the-center-for-development-and-production-of-highly-potent-drugs/

    PRESS RELEASE
    23 Oct 2025
    Share Share
    Request for quotation – RFQZ79/5914/1
    Request for quotation – RFQZ79/5914/1

    16 Oct 2025

    // PRESS RELEASE

    https://tzfpolfa.pl/en/news/request-for-quotation-rfqz79-5914-1-bioequivalence-study-empagliflozinum-25-mg-coated-tablets/

    PRESS RELEASE
    16 Oct 2025
    Share Share
    Announcement selection of audit firm external audit of project
    Announcement selection of audit firm external audit of project

    13 Sep 2024

    // PRESS RELEASE

    https://www.polfa-tarchomin.com.pl/ogloszenie-wybor-firmy-audytorskiej-audyt-zewnetrzny-projektu-opracowanie-i-rozwoj-nowej-postaci-farmaceutycznej-produktu-leczniczego/

    PRESS RELEASE
    13 Sep 2024
    Share Share
    Financing for the Construction of R&D Center & Modernization of the Laboratory
    Financing for the Construction of R&D Center & Modernization of the Laboratory

    07 Jul 2021

    // PRESS RELEASE

    https://www.polfa-tarchomin.com.pl/dofinansowania-na-budowe-centrum-badawczo-rozwojowego-oraz-modernizacje-laboratorium-do-kontroli-i-certyfikacji-masek-chirurgicznych/

    PRESS RELEASE
    07 Jul 2021
    Share Share

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Packaging

    Click here to discover the service providers for Packaging

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Polfa Tarchomin and get a quotation

    Polfa Tarchomin is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find Erythromycin bulk with DMF offered by Polfa Tarchomin

    Find Ifosfamide bulk with CEP offered by Polfa Tarchomin

    Find Disodium Pamidronate Pentahydrate bulk offered by Polfa Tarchomin

    Find Zoledronic Acid bulk offered by Polfa Tarchomin

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search